Related Experiment Video
Updated: Dec 27, 2025
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.9K
Lipids and Alzheimer's Disease.
Yu-Chia Kao1,2, Pei-Chuan Ho1, Yuan-Kun Tu3
1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
International Journal of Molecular Sciences
|February 27, 2020
Summary
Lipid homeostasis disruption is linked to Alzheimer's disease (AD). Lipidomics research is crucial for understanding AD
Area of Science:
- Neuroscience
- Biochemistry
- Metabolomics
Background:
- Lipids are fundamental cell membrane components essential for human health and brain function.
- Disrupted lipid homeostasis is implicated in neurological and neurodegenerative disorders, including Alzheimer's disease (AD).
- Aging alters lipid composition, with early AD stages showing changes in fatty acids and lipid peroxidation.
Purpose of the Study:
- To explore the intricate connection between lipids and Alzheimer's disease (AD).
- To highlight the significance of lipidomics in understanding the metabolic underpinnings of AD.
- To identify potential lipid-based biomarkers for AD prediction, diagnosis, and prevention.
Main Methods:
- Investigating alterations in fatty acid composition within lipid rafts.
- Analyzing cerebral lipid peroxidation levels.
- Examining genetic and environmental factors influencing AD, such as apolipoprotein and dietary lipid content.
- Leveraging advanced lipid analytical methodologies.
Main Results:
- Early-stage AD exhibits altered fatty acid profiles in lipid rafts.
- Cerebral lipid peroxidation is a notable finding in early AD.
- Genetic and environmental factors, including lipid metabolism and transport, are associated with AD risk.
Conclusions:
- Understanding the role of lipids in AD is vital for unraveling the disease's metabolic pathways.
- Lipidomics offers a promising avenue for discovering novel biomarkers and therapeutic targets for AD.
- Advanced lipid analysis is enhancing our comprehension of lipid involvement in AD pathogenesis.
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
01:22Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699
01:26Atherosclerosis III: Management
274
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
274
01:30Atherosclerosis I: Introduction
685
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
685
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
512
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
512
01:30Dementia
458
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
458